The Chief Executive Officer of Danadams Pharmaceuticals has had his bail restored by a court. This decision comes only one day after his bail was originally canceled.
Yaw Adu-Agyei Gyamfi, the individual involved, will continue to follow the conditions set when he was first granted bail.
These conditions include requirements related to his health and regular reporting to the authorities.
The court’s decision to restore the bail was made following a new hearing on Wednesday, March 24, 2026.
The specific reasons for the initial revocation and the subsequent restoration were not fully detailed in the court filing.
The case is ongoing, and Mr. Gyamfi is expected to comply with all stipulated bail terms.
This development affects the legal proceedings against the CEO.
Further updates will be provided as the case progresses through the judicial system.